Canine Cancer Treatment Options Compared — Surgery, Chemo, Radiation, Targeted Drugs, PD-1, mRNA Vaccines

Surgery, chemo, radiation, targeted drugs, PD-1, mRNA — six approaches, each with its role

Canine cancer treatment is a combination therapy: surgery and radiation handle visible tumors, chemotherapy clears fast-dividing cells, PD-1 inhibitors release the immune system's brakes, targeted drugs hit common mutations, and personalized mRNA vaccines target each dog's unique neoantigens. They have different roles and complement each other — mRNA immunotherapy does not replace standard care; it is an additional exploratory layer on top of your veterinarian's plan.

Treatment landscape

Therapy	Layer	Role	Key features
Surgery	Visible	Local	Removes the visible mass; also the key opportunity for tumor sampling
Radiation	Local	Local	High-energy beam to the tumor area; common for osteosarcoma, nasal tumors
Chemotherapy	Cellular	Systemic	Clears fast-dividing cells; requires assessment of side effects and condition
Targeted drugs	Molecular	Precision	Hit common mutation targets; requires sequencing to confirm the target
PD-1/PD-L1 inhibitors	Cellular	Immune modulation	Release immune "brakes"; often combined with vaccines
Personalized mRNA vaccine	Molecular	Personalized immune	Targets this dog's unique neoantigens via custom mRNA-LNP

Diagnosis path: from effect to cause

Pathology (what cancer) → immunophenotyping (cell features) → sequencing (molecular features). What you can see is the "effect"; the molecular layer is the "cause" — targeted drugs and personalized vaccines work at this layer.

Rosie-style DIY vs structured IIT: what's the difference

The Australian Rosie case (late 2025) showed the possibility of AI-assisted personalization, but differs substantially from a structured study:

Dimension	Rosie-style DIY (Australia)	Structured IIT (China)
Initiation	Owner-organized, multi-institution ad hoc	PETcura-sponsored with research partners
Design	Owner-led AI-assisted target selection & sequence design	Professional sequencing, AI neoantigen analysis, sequence design
Clinical oversight	Veterinarians supervised	Licensed veterinarians lead eligibility, injections, follow-up (principal investigators)
Enrollment checks	Case-by-case	Pathology + health + blood + LNP tolerance + informed consent
Monitoring	Individual follow-up	Systematic safety monitoring, graded AE management and reporting
Interpretation	Single case, combination therapy, no control	Systematic data collection (still exploratory; no efficacy guarantee)

⚠️ Both paths are exploratory. A single case does not represent a general result; no approach replaces standard care; always involve a licensed veterinarian.

The combination direction

Immunotherapy is not isolated: Rosie's case itself combined a vaccine with an immune checkpoint inhibitor — the vaccine activates tumor-antigen-specific responses while the checkpoint inhibitor relieves immunosuppression. Canine PD-1/PD-L1 inhibitors are used in veterinary practice, and combining them with personalized mRNA vaccines is among the exploration directions of the Chinese IIT study.

Learn more: How it works · Study details & eligibility · Owner FAQ